133 related articles for article (PubMed ID: 22740510)
21. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
22. Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure.
Qiu C; Ding SS; Hess P; Clozel JP; Clozel M
J Cardiovasc Pharmacol; 2001 Aug; 38(2):317-24. PubMed ID: 11483881
[TBL] [Abstract][Full Text] [Related]
23. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.
Sohotnik R; Nativ O; Abbasi A; Awad H; Frajewicki V; Bishara B; Sukhotnik I; Armaly Z; Aronson D; Heyman SN; Nativ O; Abassi Z
Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1099-104. PubMed ID: 23364806
[TBL] [Abstract][Full Text] [Related]
25. Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure.
Zhang PL; Mackenzie HS; Totsune K; Troy JL; Brenner BM
Circ Res; 1995 Dec; 77(6):1240-5. PubMed ID: 7586237
[TBL] [Abstract][Full Text] [Related]
26. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
27. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
29. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure.
Mullens W; Abrahams Z; Francis GS; Taylor DO; Starling RC; Tang WH
J Card Fail; 2008 Aug; 14(6):508-14. PubMed ID: 18672199
[TBL] [Abstract][Full Text] [Related]
30. Losartan decreases vasopressin-mediated cAMP accumulation in the thick ascending limb of the loop of Henle in rats with congestive heart failure.
Torp M; Brønd L; Hadrup N; Nielsen JB; Praetorius J; Nielsen S; Christensen S; Jonassen TE
Acta Physiol (Oxf); 2007 Aug; 190(4):339-50. PubMed ID: 17635349
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure.
Francis BN; Abassi Z; Heyman S; Winaver J; Hoffman A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S362-5. PubMed ID: 15838321
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
33. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
[TBL] [Abstract][Full Text] [Related]
34. [Alterations in aortic vasomotor function in rats with chronic heart failure and its mechanism].
Zhang HL; Zhao M; He X; Jiang HK; Yu XJ; Ma X; Zang WJ
Sheng Li Xue Bao; 2010 Aug; 62(4):317-24. PubMed ID: 20717632
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J
Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375
[TBL] [Abstract][Full Text] [Related]
36. BACE1 levels are elevated in congestive heart failure.
Nural-Guvener HF; Mutlu N; Gaballa MA
Neurosci Lett; 2013 Jan; 532():7-11. PubMed ID: 23127855
[TBL] [Abstract][Full Text] [Related]
37. Cardiorenal syndrome in decompensated heart failure.
Tang WH; Mullens W
Heart; 2010 Feb; 96(4):255-60. PubMed ID: 19401280
[TBL] [Abstract][Full Text] [Related]
38. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
39. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
[TBL] [Abstract][Full Text] [Related]
40. Effects of N-acetyl-L-cysteine on renal haemodynamics and function in early ischaemia-reperfusion injury in rats.
Nitescu N; Grimberg E; Ricksten SE; Guron G
Clin Exp Pharmacol Physiol; 2006; 33(1-2):53-7. PubMed ID: 16445699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
